Skip to content
TrialScanner

NCT05182073

FT576 in Subjects With Multiple Myeloma

Phase 1CompletedFATELead

Registry record

Lead sponsor
Fate Therapeutics
Conditions
Multiple Myeloma; Myeloma
Primary completion
Sep 20, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05182073 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05182073: FT576 in Subjects With... | TrialScanner